Abstract
Recent studies indicate that COVID-19 has had a significant impact on access and continuity to opioid and benzodiazepine medications; little is known about its effect on access to and utilization of stimulant medications.
- Title
- Prescribed stimulant medications: Trends in the last decade, pre and post COVID-19 response
- Creators
- Meelee Kim (Corresponding Author) - Institute for Behavioral Health, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USANetrali Dalvi (Author) - Office of Prescription Monitoring and Drug Control, Bureau of Health Professional Licensure, Massachusetts Department of Public Health, Boston, MA, USADanielle DeNufrio Valerio (Author) - Office of Prescription Monitoring and Drug Control, Bureau of Health Professional Licensure, Massachusetts Department of Public Health, Boston, MA, USAGail Strickler (Author)Leonard D Young (Author) - Office of Prescription Monitoring and Drug Control, Bureau of Health Professional Licensure, Massachusetts Department of Public Health, Boston, MA, USA
- Publication Details
- Exploratory research in clinical and social pharmacy, Vol.11, pp.100314-100314
- Publisher
- Elsevier
- Identifiers
- 9924340173001921
- Academic Unit
- Heller School for Social Policy and Management
- Language
- English
- Resource Type
- Journal article